Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
G-CSF for pregnancy rate in endometriosis and RIF
NCT03549728Phase 2Unknown
- Start
- Jun 2018
- Primary completion
- Oct 2018
01
Overview
A Phase 2 trial of filgrastim in Recurrent Implantation Failure (RIF). Status: unknown.
02
Drugs
filgrastim
03
Conditions
Recurrent Implantation Failure (RIF)
Beyond the preview
Go deeper on NCT03549728.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03549728.